Expected strategic result 2.7.1.3. The specific considerations of procurement of medications and medical devices necessitated by the pandemic or carried out during the pandemic are established in such a way as to prevent corruption risks

Information about ESR Feedback from the public
Progress in the implementation of measures as of 21.11.2024
measures, the implementation of which as of 30.09.2024
4 1
5
Implemented Partially implemented
Measures implemented (fully and partially) - 5 ( 100%)
Display in tabular form

Measures — 5

2.7.1.3.1. Arranging an analytical study on the assessment of corruption risks in the procurement of medications and medical devices necessitated by the pandemic or conducted during the pandemic, with the presentation of statistical, economic, and other data, as well as the relevant proposals on how to prevent the identified corruption risks and to enhance the transparency and effectiveness of the procurement procedures in question

The main implementer: Ministry of Health of Ukraine

2.7.1.3.2. Holding a presentation of the report on the findings of the analytical study indicated in subclause 2.7.1.3.1, followed by its discussion with stakeholders

The main implementer: Ministry of Health of Ukraine

2.7.1.3.3. Drafting normative legal acts on amendments to normative legal acts, taking into account the findings of the analytical study indicated in subclause 2.7.1.3.1 (if needed)

The main implementer: Ministry of Health of Ukraine

2.7.1.3.4. Holding a public discussion of the draft normative legal acts indicated in subclause 2.7.1.3.3 (if needed)

The main implementer: Ministry of Health of Ukraine

2.7.1.3.5. Final revision (if needed) and approval of the draft normative legal acts indicated in subclause 2.7.1.3.3 (if needed)

The main implementer: Ministry of Health of Ukraine

Indicators — 2

Evaluation of achievement of ESR — indicator weight —
1
0 / 90%

An analytical report has been published on the findings of the analytical study on the assessment of corruption risks in the procurement of medications and medical devices necessitated by the pandemic or conducted during the pandemic, with the presentation of proposals on how to prevent the identified corruption risks and to enhance the transparency and effectiveness of the procurement procedures.

i
2
0 / 10%

Amendments to normative legal acts have come into force, which pertain to the specific considerations of procurement of medications and medical devices necessitated by the pandemic or carried out during the pandemic, taking into account the findings of the analytical study indicated in subclause 1 of clause 2.7.1.3.

i
* - certain measures are common to several ESRs, but have a separate number (id)